First, to determine whether there is an imbalance of CD4+ T and CD8+ T cells in HCC, we measured the percentage of CD4+ T and CD8+ T cells in peripheral blood lymphocytes (PBMCs) from HCC patients and normal control samples. This evidence concerns the gene CD8A and hepatocellular carcinoma.